oncodaily.com·2 min read·hard
Oriol Mirallas Publishes Review on Targeting Regulatory T Cells for Cancer Immunotherapy
M
Mane Hovhannisyan
✦AI Summary
Oriol Mirallas and colleagues have published a review in the Annals of Oncology regarding the targeting of regulatory T cells for cancer immunotherapy. The paper explores the biological complexities and potential therapeutic strategies for this approach.
Oriol Mirallas , Clinical Fellow in the Investigational Cancer Therapeutics (ICT) Department at the University of Texas MD Anderson Cancer Center, shared a post on LinkedIn :
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in